Marco Stellato; Sebastiano Buti; Marco Maruzzo; Maria Bassanelli; Melissa Bersanelli; Marilena Di Napoli; Michele Dionese; Martina Fanelli; Roberto Filippi; Giuseppe Fotia; Luca Galli; Francesco Grillone; Michele Maffezzoli; Brigida Anna Maiorano; Cecilia Nasso; Sara Elena Rebuzzi; Luca Lalli; Giandomenico Roviello; Mariella Sorarù; Bruno Vincenzi; Giuseppe Procopio; Elena Verzoni. Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27. Clinical Genitourinary Cancer 2024, 22, 102078 .

Marco Stellato, Sebastiano Buti, Marco Maruzzo, Maria Bassanelli, Melissa Bersanelli, Marilena Di Napoli, Michele Dionese, Martina Fanelli, Roberto Filippi, Giuseppe Fotia, Luca Galli, Francesco Grillone, Michele Maffezzoli, Brigida Anna Maiorano, Cecilia Nasso, Sara Elena Rebuzzi, Luca Lalli, Giandomenico Roviello, Mariella Sorarù, Bruno Vincenzi, Giuseppe Procopio, Elena Verzoni. Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27. Clinical Genitourinary Cancer. 2024; 22 (3):102078.

Marco Stellato; Sebastiano Buti; Marco Maruzzo; Maria Bassanelli; Melissa Bersanelli; Marilena Di Napoli; Michele Dionese; Martina Fanelli; Roberto Filippi; Giuseppe Fotia; Luca Galli; Francesco Grillone; Michele Maffezzoli; Brigida Anna Maiorano; Cecilia Nasso; Sara Elena Rebuzzi; Luca Lalli; Giandomenico Roviello; Mariella Sorarù; Bruno Vincenzi; Giuseppe Procopio; Elena Verzoni. 2024. "Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27." Clinical Genitourinary Cancer 22, no. 3: 102078.

Andrew J. Hayes; David J. Coker; Lukas Been; Veerle Wsm. Boecxstaens; Sylvie Bonvalot; Franco De Cian; Luis de la Cruz-Merino; Carlos Duarte; Alexander Eggermont; Victor Farricha; Marco Fiore; Dirk Grünhagen; Robert Grützmann; Charles Honoré; Jens Jakob; Marko Hocevar; Winan van Houdt; Joseph Klauzner; Christoph Kettelhack; Angela Märten; Hector Martinez-Said; Maurice Matter; Audrey Michot; Maya Niethard; Elisabetta Pennacchioli; Lars E. Podleska; Gregorio Rabago; Marco Rastrelli; Sophie Reijers; Matilde Ribeiro; Matthias Schwarzbach; Hayden A. Snow; Miroslav Spacek; Stephan Stoldt; Alessandro Testori; Odysseas Zoras; Roger Olofsson Bagge. Technical considerations for isolated limb perfusion: A consensus paper. European Journal of Surgical Oncology 2024, 50, 108050 .

Andrew J. Hayes, David J. Coker, Lukas Been, Veerle Wsm. Boecxstaens, Sylvie Bonvalot, Franco De Cian, Luis de la Cruz-Merino, Carlos Duarte, Alexander Eggermont, Victor Farricha, Marco Fiore, Dirk Grünhagen, Robert Grützmann, Charles Honoré, Jens Jakob, Marko Hocevar, Winan van Houdt, Joseph Klauzner, Christoph Kettelhack, Angela Märten, Hector Martinez-Said, Maurice Matter, Audrey Michot, Maya Niethard, Elisabetta Pennacchioli, Lars E. Podleska, Gregorio Rabago, Marco Rastrelli, Sophie Reijers, Matilde Ribeiro, Matthias Schwarzbach, Hayden A. Snow, Miroslav Spacek, Stephan Stoldt, Alessandro Testori, Odysseas Zoras, Roger Olofsson Bagge. Technical considerations for isolated limb perfusion: A consensus paper. European Journal of Surgical Oncology. 2024; 50 (6):108050.

Andrew J. Hayes; David J. Coker; Lukas Been; Veerle Wsm. Boecxstaens; Sylvie Bonvalot; Franco De Cian; Luis de la Cruz-Merino; Carlos Duarte; Alexander Eggermont; Victor Farricha; Marco Fiore; Dirk Grünhagen; Robert Grützmann; Charles Honoré; Jens Jakob; Marko Hocevar; Winan van Houdt; Joseph Klauzner; Christoph Kettelhack; Angela Märten; Hector Martinez-Said; Maurice Matter; Audrey Michot; Maya Niethard; Elisabetta Pennacchioli; Lars E. Podleska; Gregorio Rabago; Marco Rastrelli; Sophie Reijers; Matilde Ribeiro; Matthias Schwarzbach; Hayden A. Snow; Miroslav Spacek; Stephan Stoldt; Alessandro Testori; Odysseas Zoras; Roger Olofsson Bagge. 2024. "Technical considerations for isolated limb perfusion: A consensus paper." European Journal of Surgical Oncology 50, no. 6: 108050.

The Cancer Genome Atlas (TCGA) has radically changed the history of endometrial cancer by outlining a new classification, based on its molecular characteristics. In the field of oncology, we are approaching the new era of molecular biology, particularly regarding endometrial cancer, with the increasing importance of targeted therapy. This paper is a review of phase III randomized controlled trials published in English between January 2019 and December 2023, comparing drugs of interest with standard adjuvant treatment and molecular subtypes in endometrial cancer. The use of immunotherapy alone or in combination with chemotherapy as therapy in patients with recurrent or advanced primary or metastatic endometrial cancer significantly improves the prognosis of these patients. The results show greater efficacy of all proposed treatments for mismatch repair deficiency (dMMR/MSI-H) patients compared to mismatch repair proficiency (pMMR) patients. Progression-free survival (PFS) and overall survival (OS) are better in dMMR patients in all studies analysed. Immunotherapy has the potential to revolutionize the gynaecological cancer treatment landscape, offering a new pathway and new hope for endometrial cancer patients, improving their outcomes in the future. Given the exciting results obtained in dMMR/MSI-H patients, MMR status should be investigated in every patient with advanced endometrial cancer at the time of diagnosis.

Daniela Luvero; Gianna Barbara Cundari; Fernando Ficarola; Francesco Plotti; Corrado Terranova; Roberto Montera; Giorgio Bogani; Adele Silvagni; Federica Celoro; Roberto Angioli. Old Issues and New Perspectives on Endometrial Cancer Therapy: How Molecular Characteristics Are Changing the Therapeutic Pathway. Cancers 2024, 16, 1866 .

Daniela Luvero, Gianna Barbara Cundari, Fernando Ficarola, Francesco Plotti, Corrado Terranova, Roberto Montera, Giorgio Bogani, Adele Silvagni, Federica Celoro, Roberto Angioli. Old Issues and New Perspectives on Endometrial Cancer Therapy: How Molecular Characteristics Are Changing the Therapeutic Pathway. Cancers. 2024; 16 (10):1866.

Daniela Luvero; Gianna Barbara Cundari; Fernando Ficarola; Francesco Plotti; Corrado Terranova; Roberto Montera; Giorgio Bogani; Adele Silvagni; Federica Celoro; Roberto Angioli. 2024. "Old Issues and New Perspectives on Endometrial Cancer Therapy: How Molecular Characteristics Are Changing the Therapeutic Pathway." Cancers 16, no. 10: 1866.